// App-Quantinova.ai

816 : Genetic variants in the dopaminergic system and bladder cancer clinical outcomes

Researchers

Presenter

  • Jeanne A. Pierzynski

Principal Investigators

  • Yuanquing Ye

  • Alma Rodriguez

  • Michelle A.T. Hildebrandt

  • Ashish M. Kamat

  • Colin P.N. Dinney

  • Xifeng Wu

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Depression

  • Solid malignancies

Biomarkers

  • Brain-derived neurotrophic factor

  • Catechol-O-Methyltransferase

  • Body mass index

Drug/Treatment

  • Dopamine hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved